ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Puerto Rico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HERIBERTO ACOSTA M.D.

Neurology

16,677

$1.7M

1023
957 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 34%

$102
Average prescription price

Avg: $113

IRIS ACEVEDO M.D.

Neurology

13,995

$1.58M

1071
662 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 34%

$113
Average prescription price

Avg: $113

AMARILIS CORCHADO PEREZ MD

Neurology

13,563

$1.46M

1036
624 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 34%

$108
Average prescription price

Avg: $113

LUIS FORASTIERI M.D.

Neurology

13,114

$1.32M

1303
999 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 34%

$100
Average prescription price

Avg: $113

RAUL MARCO BORRULL M.D.

Neurology

12,140

$1.04M

736
502 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 34%

$86
Average prescription price

Avg: $113

ALFREDO PEREZ CANABAL MD

Neurology

12,070

$2.27M

1442
1063 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 34%

$188
Average prescription price

Avg: $113

MARY KAREN PENA M.D.

Neurology

10,183

$1.04M

1241
884 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 34%

$103
Average prescription price

Avg: $113

HECTOR CASES MAYORAL MD

Neurology

9,442

$364K

1260
286 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 34%

$39
Average prescription price

Avg: $113

MERBIL GONZALEZ DIAZ M.D.

Neurology

8,061

$789K

812
626 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 34%

$98
Average prescription price

Avg: $113

FRANCISCO VAZQUEZ REILLO M.D.

Neurology

7,457

$1.08M

923
640 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 34%

$145
Average prescription price

Avg: $113

JAIME ROSA MD

Neurology

6,747

$732K

954
790 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 34%

$109
Average prescription price

Avg: $113

WINSTON ORTIZ CINTRON MD

Neurology

6,736

$651K

673
460 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 34%

$97
Average prescription price

Avg: $113

LUCE VILLAFANE CARMONA

Neurology

6,708

$298K

412
242 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 34%

$44
Average prescription price

Avg: $113

BRENDA CHAAR M.D.

Neurology

6,593

$473K

712
578 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 34%

$72
Average prescription price

Avg: $113

LUIS FREYTES LUGO M.D.

Neurology

6,502

$633K

1068
800 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 34%

$97
Average prescription price

Avg: $113

TERESA CASTRO PONCE

Neurology

5,716

$721K

514
424 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 34%

$126
Average prescription price

Avg: $113

GIAN GIERBOLINI M.D.

Neurology

5,462

$617K

746
567 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 34%

$113
Average prescription price

Avg: $113

CARLOS OTERO MD

Neurology

5,453

$471K

822
677 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 34%

$86
Average prescription price

Avg: $113

EDGAR HERNANDEZ MD

Neurology

5,362

$444K

848
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 34%

$83
Average prescription price

Avg: $113

MARINA RIVERA-VIRELLA M.D.

Neurology

5,351

$589K

458
391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 34%

$110
Average prescription price

Avg: $113

NICOLAS PEREZ MALDONADO M.D.

Neurology

5,119

$1.24M

334
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 34%

$241
Average prescription price

Avg: $113

REINALDO CARRERAS MD

Neurology

4,916

$275K

475
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 34%

$56
Average prescription price

Avg: $113

JUAN MOREIRA M.D.

Neurology

4,758

$611K

524
453 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 34%

$128
Average prescription price

Avg: $113

OSCAR BAEZ-SORIA M.D.

Neurology

4,605

$392K

592
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 34%

$85
Average prescription price

Avg: $113

ANGEL CHINEA M.D.

Neurology

4,420

$2.95M

495
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 34%

$667
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank